Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,274 | 30,134 | -15,311 | -5,197 | -34,105 |
| Depreciation Amortization | 2,993 | 2,267 | 1,525 | 759 | 4,556 |
| Accounts receivable | N/A | N/A | N/A | 34 | N/A |
| Accounts payable and accrued liabilities | 1,483 | 1,158 | 822 | 684 | 923 |
| Other Working Capital | -3,685 | 3,631 | 2,007 | 1,065 | -2,299 |
| Other Operating Activity | -58,839 | -65,189 | -3,992 | -5,142 | -3,367 |
| Operating Cash Flow | $-44,775 | $-27,999 | $-14,949 | $-7,797 | $-34,292 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -933 | 1 | 1 | 1 | -337 |
| Purchase Of Investment | -142,036 | -129,992 | -123 | -71 | -37,446 |
| Sale Of Investment | 21,262 | 9,991 | 9,991 | 4,742 | 25,821 |
| Investing Cash Flow | $-121,706 | $-120,000 | $9,869 | $4,671 | $-11,962 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 516 |
| Debt Repayment | -143 | -106 | -70 | -35 | -132 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 20 |
| Other Financing Activity | 168,442 | 168,447 | -278 | -139 | -1,577 |
| Financing Cash Flow | $168,300 | $168,341 | $-348 | $-174 | $-1,173 |
| Exchange Rate Effect | -214 | 184 | 222 | 43 | -241 |
| Beginning Cash Position | 8,898 | 8,898 | 8,898 | 8,898 | 56,566 |
| End Cash Position | 10,503 | 29,425 | 3,692 | 5,640 | 8,898 |
| Net Cash Flow | $1,605 | $20,527 | $-5,206 | $-3,258 | $-47,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,775 | -27,999 | -14,949 | -7,797 | -34,292 |
| Capital Expenditure | -933 | N/A | N/A | N/A | -337 |
| Free Cash Flow | -45,708 | -27,999 | -14,949 | -7,797 | -34,629 |